- US-listed companies
- BIOLASE, INC
- Income statement
BIOLASE, INC【BIOLQ】Income statement
Market cap
$36.6
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | |
| Revenue | 49 | 57 | 56 | 48 | 48 | 52 | 47 | 46 | 38 | 23 | - | - | - |
| Revenue growth (%) | - | - | - | - | |||||||||
| Cost of revenue | 28 | 31 | 35 | 29 | 33 | 32 | 32 | 29 | 24 | 17 | - | - | - |
| Gross profit | 21 | 26 | 22 | 18 | 16 | 20 | 15 | 17 | 14 | 6 | - | - | - |
| Gross margin (%) | - | - | - | ||||||||||
| Research & development | 4 | 5 | 4 | 5 | 7 | 8 | 6 | 5 | 5 | 4 | - | - | - |
| Operating margin (%) | - | - | - | ||||||||||
| Operating expenses | 25 | 29 | 33 | 36 | 36 | 35 | 33 | 38 | 30 | 25 | - | - | - |
| Operating income | -4 | -3 | -11 | -18 | -20 | -15 | -18 | -21 | -16 | -19 | - | - | - |
| Income before tax | -4 | -3 | -12 | -19 | -20 | -15 | -17 | -21 | -18 | -17 | - | - | - |
| Pretax margin (%) | -9 | -5.1 | -20.6 | -39.5 | -41.5 | -29.4 | -37.1 | -46.5 | -47.4 | -73.3 | - | - | - |
| Provision for income taxes | 0 | 0 | -0 | 0 | 0 | 0 | -1 | 0 | -0 | 0 | - | - | - |
| Effective tax rate (%) | - | - | - | ||||||||||
| Net income | -4 | -3 | -11 | -19 | -20 | -15 | -17 | -22 | -18 | -17 | -16 | -29 | -21 |
| Net income margin (%) | - | - | - | ||||||||||
| Earnings per share | -0.15 | -0.1 | -0.35 | -0.45 | -0.35 | -0.29 | -0.28 | -1.05 | -0.77 | -0.56 | - | - | - |
| Diluted EPS | -0.15 | -0.1 | -0.35 | -0.45 | -0.35 | -0.29 | -0.28 | -1.05 | -0.77 | -0.56 | - | - | - |
| EBITDA | - | - | - | ||||||||||
| EBITDA margin (%) | - | - | - |